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Carol Brayne2 and The CC75C Study
Abstract
Background: The assessment of Health Related Quality of Life (HRQL) is important in people with dementia as it
could influence their care and support plan. Many studies on dementia do not specifically set out to measure
dementia-specific HRQL but do include related items. The aim of this study is to explore the distribution of HRQL
by functional and socio-demographic variables in a population-based setting.
Methods: Domains of DEMQOL’s conceptual framework were mapped in the Cambridge City over 75’s Cohort
(CC75C) Study. HRQL was estimated in 110 participants aged 80+ years with a confirmed diagnosis of dementia
with mild/moderate severity. Acceptability (missing values and normality of the total score), internal consistency
(Cronbach’s alpha), convergent, discriminant and known group differences validity (Spearman correlations, Wilcoxon
Mann-Whitney and Kruskal-Wallis tests) were assessed. The distribution of HRQL by socio-demographic and
functional descriptors was explored.
Results: The HRQL score ranged from 0 to 16 and showed an internal consistency Alpha of 0.74. Validity of the
instrument was found to be acceptable. Men had higher HRQL than women. Marital status had a greater effect on
HRQL for men than it did for women. The HRQL of those with good self-reported health was higher than those
with fair/poor self-reported health. HRQL was not associated with dementia severity.
Conclusions: To our knowledge this is the first study to examine the distribution of dementia-specific HRQL in a
population sample of the very old. We have mapped an existing conceptual framework of dementia specific HRQL
onto an existing study and demonstrated the feasibility of this approach. Findings in this study suggest that
whereas there is big emphasis in dementia severity, characteristics such as gender should be taken into account
when assessing and implementing programmes to improve HRQL.
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Background
Dementia is the most common disorder of old age [1,2]
and a leading cause of mortality and disability in high in-
come countries [3]. Medications temporarily relieve symp-
toms for some individuals, but do not modify the overall
course of the disease, [4]. Narrow assessment of cognition
and functional ability is insufficient for clinical decision-
making and policy development as they only reflect a part
of the impact of dementia [5]. Dementia can also have a
significant impact on quality of live (QoL). Indeed, treat-
ment is increasingly focused on improving or maintaining
optimal QoL and this has become a key outcome for evalu-
ating the effectiveness of dementia interventions [5-7].
Health-related quality of life (HRQL) can be defined as
an individual’s perception of the impact of a health con-
dition on their everyday life [8]. HRQL differs from the
broader concept of QoL in that it includes only aspects
of QoL that are affected by a health condition. Despite
the lack of agreement on what domains constitute HRQL,
it is generally agreed that the concept is multidimensional
and subjective and that any assessment should include
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measurement of positive and negative dimensions [9-12].
There have been many efforts to capture HRQL in de-
mentia including generic and dementia-specific HRQL
measures. Generic HRQL measures are not tailored to
people with dementia [13,14]. Such measures focus on
health and function and imply that HRQL will automatic-
ally decrease with disease progression. Some generic mea-
sures (e.g., Nottingham Health Profile [15], Duke Health
Profile [16]) have been found to lack evidence on validity
or reliability in dementia populations [17]. A recent recent
systematic review on HRQL in dementia found that there
are at least 15 different dementia specific HRQL scales
[18]. Some of the most widely used include: the Quality of
Life in Alzheimer’s Disease (QoL-AD) [19], Alzheimer’s
Disease Related Quality of Life (ADRQL) [13], QUALIDEM
[20], Quality Of Life Assessment Schedule (QOLAS) [21]
and the DEMQOL [22]. Each of these measures a wide
range of dimensions and their use has been found to be
beneficial within a clinical framework. However, there are
limitations with each. For example, while the QoL-AD has
been validated in numerous countries it includes items on
functioning and cognition implying that HRQL will de-
crease automatically with disease progression. The ADRQL
can obtain both total and subscale scores. However it is a
proxy-rated only measure and therefore is not the most
suitable measure for use in individuals with mild-moderate
dementia. The same applies to the QUALIDEM. In the
QOLAS scale, while the subdomains are chosen by the pa-
tient, making this one of the most suitable measures for
clinical practice, this limits its utility for research purposes
since the concept of HRQL is intrinsic to the person. The
DEQMOL’s conceptual framework was developed by litera-
ture review and interviews with people with dementia and
their carers. There is a self and a proxy-rated version. How-
ever, in a clinical sample, factor analysis showed a lack of
dimensionality. Lastly, a limitation of all scales is that none
has been validated in a population-based sample.
Although research on HRQL has increased in the last
decade, there is still limited evidence on how it is af-
fected by dementia [23]. Knowledge of this is necessary
to measure the impact of early diagnosis, access to treat-
ment and effective planning of care. To our knowledge no
study has assessed HRQL with dementia-specific mea-
sures in a population-based setting. While many popula-
tion studies focused on dementia do not specifically set
out to measure dementia-specific HRQL, they do include
related items such as mood or social support. Mapping
measures of HRQL in such studies is important for deter-
mining the distribution of HRQL and its risk factors in
the dementia population. Therefore, the aim of this study
was to explore the distribution of HRQL by functional
and socio-demographic variables, mapped using items of
the DEMQOL scale, using data from the Cambridge City
over 75s Cohort (CC75C).
Methods
Sample and design
Participants were from the CC75C study, a population-based
longitudinal cohort study representative of Cambridge’s
(UK) older people. Full details of the methodology has
been described elsewhere [24] and can be found online at
can be found on line at http://www.cc75c.group.cam.ac.uk/.
The baseline survey enrolled 95% (n = 2610) of individuals
aged 75 years and older, approached from six general prac-
tices in Cambridge in 1985/87. Participants were followed
with surveys repeated at two (Survey 2), seven (Survey 3),
ten (Survey 4), 13 (Survey 5), 17 (Survey 6) and 21 years
(Survey 7). Interviews were conducted with the study
participants and a proxy informant if the participant was
unable to complete the interview. Proxy informants were
usually relatives but could sometimes be a friend/
neighbour or a warden or member of staff in a care home.
Observations by the interviewer were also gathered during
the course of the interviews. Core data included informa-
tion on socio-demographic variables (e.g. place of resi-
dence, household structure, marital status and social
contact), activities of daily living (ADLs), use of health and
social services, cognitive function (e.g., Mini Mental State
Examination (MMSE) [25]), health problems and medica-
tion. This data except for HRQL and cognitive assess-
ments was retrieved from the caregivers if necessary. The
interview schedule has undergone slight revisions with the
addition of new sections, such as questions on affect and
loneliness added in survey 3 and 4. Survey 3, conducted in
the 7th year of follow up, was the first survey that best rep-
resented all the DEMQOL domains, with questions includ-
ing socio-demographic information, social relationships,
mood, loneliness, anxiety, depression, ADLs and cognitive
functioning. Therefore data from Survey 3 will be used in
this analysis.
Dementia diagnosis
Dementia was diagnosed using a two-stage approach. At
baseline, individuals who scored ≤ 23 on the MMSE, and
one in three individuals with a MMSE score of 24 or 25,
were assessed using the Cambridge Mental Disorders of
the Elderly Examination (CAMDEX) [26], a structured
schedule specifically designed to detect mild dementia.
Between the baseline interview and survey 3, six assess-
ments for dementia were conducted. Based on the CAMDEX
results, different dementia types were assessed including:
Alzheimer’s disease (AD), vascular dementia (VaD), mixed
(AD and VaD), dementia secondary to other causes,
clouded/delirious state plus AD and clouded/delirious
state plus VaD. Dementia diagnoses were also sought by
checking death certificates for any mention of dementia as
a cause of death and checking reports from interviews
with relatives for the sub-sample of participants who do-
nated their brains to research. No additional people with
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dementia were identified. For the present study, par-
ticipants with a last diagnosis of dementia, from any
CAMDEX assessment and MMSE score > 10 (n = 110,
40 men and 70 women aged 80-99) up until one year after
Survey 3 were identified for inclusion in this analysis.
Among those without a MMSE score, 2 people were diag-
nosed with minimal, 2 with mild and 2 with moderate
dementia using the CAMDEX. The staging of demen-
tia was calculated using cut-offs on the MMSE as fol-
lows: 11–20 = moderate; 21 and above = mild [27].
Assessment of socio-demographic and functional ability
Socio-demographic variables included age (continuous), gen-
der, marital status (currently married, widowed, separated/
divorced, and never married), education (up to 14 years of
age and 15 and above) and accommodation (house, war-
den controlled housing, residential home and long stay hos-
pital). Functional disability included impairment in basic
and instrumental ADLs (IADLs). Individuals were cate-
gorised into three groups based on their pattern of impair-
ment including: (1) IADL disability only if they required
help with cooking, housework or both; (2) ADL + IADL
disability if they needed help with any of four basic ADL
tasks including: bathing, dressing, getting to the toilet on
time and grooming; or, (3) No ADL/IADL disability.
Questionnaire mapping and development
In this study we chose to map the DEMQOL framework as
it includes the domains that have been most commonly
assessed in dementia-specific HRQL measures, namely
daily activities/looking after yourself, health and well-being,
cognitive functioning, social relationships, and self-concept.
Further, the conceptual framework underpinning the DEM-
QOL was developed in in the UK. Using data obtained at
Survey 3, the following subdomains of the DEMQOL
framework could be mapped including: health and well-
being, social relationships, self-concept and items from
daily activities corresponding to enjoyment of activities.
Only self-reported information was used to assess HRQL.
Due to the high percentage of missing responses to HRQL
items in the most cognitively impaired participants, only
those with a MMSE score above 10 were included in the
study, as has been suggested previously [28-30].
Table 1 shows the DEMQOL conceptual framework and
the subdomains that could be mapped in the CC75C study.
After mapping, 18 items were included. After applying
existing criteria for missing data analysis, inter-item corre-
lations and endorsement frequencies analysis [22], two of
these items were removed, giving a scale ranging from 0 to
16 with 0 being the lowest and 16 the highest scores.
Analysis
The psychometric properties of the final version of the
questionnaire (16 items) were tested with the sample of
110 people with dementia identified as described above.
Standard psychometric methods were used [31] to evalu-
ate acceptability, reliability (internal consistency) and val-
idity (content, convergent, discriminant and known group
differences). Criteria for acceptability were: missing data
for summary scores <5% and normality of the distribution
of the total score (Skewness measured with Shapiro-
Francia, Shapiro-Wilk and Skewness test with a p value
higher than 0.05 indicating normality). Criteria for internal
consistency were Cronbach’s alpha ≥0.7. Convergent and
discriminant validity were measured with Spearman corre-
lations (r). Convergent validity is the evidence that the
scale is correlated with other measures of the same or
similar constructs and was deemed acceptable when r was
0.20 and higher. Discriminant validity is the evidence that
the scale is not correlated with measures of different con-
structs and was deemed acceptable when r was below
0.20. Known group differences refer to the ability of a scale
to differentiate groups who are expected to differ on the
construct being measured. Differences in HRQL scores by
socio-demographic, functional and measures of disability
and cognition were tested using the Wilcoxon Mann-
Whitney tests (variables with two groups) and Kruskal-
Wallis test (variables with more than two groups). Statistical
significance was set at p < 0.05. A meta-analytical review
was conducted in order to generate a priori hypotheses as
part as the validity assessment of the measure used. This
has been annexed as a separate report (Additional file 1) as
a separate report. We used factor analysis to evaluate
hypothesised subscales based on the conceptual frame-
work. All analyses were performed using Stata 11 [32].
Ethics approval and consent
Each CC75C study phase was approved by Cambridge
Research Ethics Committee and National Research Ethics
Service Committee East of England- Cambridge Central
(Reference numbers: 05_Q0108_308 and 08_H0308_3).
Written informed consent was obtained from all partici-
pants. For those deemed to lack capacity to give fully in-
formed consent, and those unable to give consent in writing
for reasons of physical disability, both the study participant’s
clear assent to be interviewed and written proxy informed
consent from a relative or caregiver well known to the par-
ticipant were attained.
Results
Description of sample
A description of the sample can be found in Table 2.
Out of the 713 people who took part in Survey 3, there
were 134 people with a dementia diagnosis. From these,
we excluded n = 24 with MMSE scores 0-10. Diagnoses
included Alzheimer’s disease (69.1%), vascular dementia
(3.6%), mixed dementia (22.7%) and other dementia (4.6%).
Age ranged from 81 to 99 years (mean age 86.6, SD 3.6),
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Table 1 DEMQOL conceptual framework and mappin
DEMQOL domain Item in the CC75C study
Daily activities1
-getting around NA
-keeping yourself clean NA
-keeping yourself looking
nice
NA
-going to the toilet NA
-using knife and fork NA
-getting the things you
need from the shops
NA
-getting in touch with
people when you need to
NA
-getting meals NA
-taking care of the house NA
-getting where you need
to go
NA
-taking care of your
finances
NA
-using money to buy
everyday things
NA
-choice about how to
spend your time
No
-things that you want
to do but you can’t
No
-being able to enjoy
what you do
The things I do are as interesting to me
as they ever were
Have you lost pleasure or interest in
doing things you usually cared about or
enjoyed?
Cognitive functioning1
-memory for recent events NA
-memory for names NA
-concentration NA
-orientation in time,
place and person
NA
-clarity of thought NA
-making your mind up NA
-communication NA
Self-concept
-self-esteem No
-presentation of self No
-sense of independence No
-satisfaction with past life No
-satisfaction with present life No
-hopes and aspirations
for the future
How do you feel about the future?
-feeling useful No
Table 1 DEMQOL conceptual framework and mappin
(Continued)
Health and well-being
-global health rating How would you rate your physical health
compared to a year ago?
-happiness-depression I am just as happy as when I was
younger
-contentment-frustration No
-enjoying life-enjoying
nothing
Would you say that you enjoy your life?
-confidence No
-embarrassment No
-anxiety Do you feel more tense and worry more
than usual about little things?
-lively-weary Would you say you have more or less
energy at the moment than you did a
year ago?
-loneliness Do you feel lonely?
-somatic complaints Have you had more trouble sleeping
recently than is normal for you?
Have you lost (or gained) a lot of weight
in the last six months?
-feeling safe No
-cheerful No
-relaxed No
-irritable Have you felt more irritable lately?
-angry No
-resentful No
-sad Do you feel sad or depressed or
miserable?
-distressed No
Social relationships
-treatment by others No
-social interaction No
-reciprocity Is there anyone whom you help with
anything?
-social integration No
-companionship No
-social support There are members of my family (friends)
who can be relied on no matter what
happens
-intimacy and physical
affection
In general, do you have as much contact
with family and friends as you would
like to?
-other emotional
relationships
No
1Cognition and other daily activities were excluded since they are symptoms
of dementia.
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Table 2 Socio-demographic profile of the sample
Sociodemographic and health
status variables by sex
Men (n = 40) Women (n = 70) Total (n = 110)
n % n % n %
Age
Mean (SD) 86.6 4.0 86.2 3.4 86.6 3.6
Range 81 96 81 96 81 96
81–84 19 47.5 30 42.9 49 44.5
85–89 14 35.0 32 45.7 46 41.5
90+ 7 17.5 8 11.4 15 13.6
Education
Left school <15 years old 29 72.5 49 70.0 78 70.9
Left school ≥15 years old 11 27.5 21 30.0 32 29.1
Accommodation
House/flat/granny flat 28 70.0 50 71.4 78 70.9
Warden controlled/sheltered housing 7 17.5 11 15.7 18 16.4
Residential home 4 10.0 9 12.9 13 11.8
Long stay hospital 1 2.5 0 0.0 1 0.9
Marital status
Married 16 40.0 10 14.3 26 23.6
Widowed 20 50.0 54 77.1 74 67.3
Separated/divorced 0 0.0 1 1.4 1 0.9
Never married 4 10.0 5 7.1 9 8.2
Disability
No ADL or IADL 13 32.5 22 31.4 35 31.8
IADL only 18 45.0 16 22.9 34 30.9
ADL + IADL 9 22.5 31 44.3 40 36.4
Missing 0 0.0 1 1.4 1 0.9
MMSE
Mean (SD) 22.0 4.7 20.9 4.8 21.3 4.8
Range 13 30 11 29 11 30
Moderate 14 35.0 30 42.9 44 40.0
Mild 26 65.0 40 57.1 66 60.0
Self-rated health
Very good/good 34 85.0 52 74.3 86 78.2
Fair/very poor 4 10.0 10 14.3 14 12.7
Missing 2 4.7 8 10.8 10 8.6
Dementia type
Alzheimer’s Disease (AD) 30 75.0 46 65.7 76 69.9
Vascular Dementia (VD) 1 2.5 3 4.3 4 3.6
Mixed (AD + VD) 7 17.5 18 25.7 25 22.7
Dementia secondary to other causes 1 2.5 1 1.4 2 1.8
Clouded/delirious state + AD 0 0.0 2 2.9 2 1.8
Clouded/delirious state + VD 1 2.5 0 0.0 1 0.9
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63.6% were women and 29.1% of the sample left school at
age 15 or later. A high percentage of the sample lived in a
house or flat (70.9%), 16.4% lived in warden controlled shel-
tered housing and 11.8% in a residential home. Most partic-
ipants were widowed (77.1%), with less than a quarter of
the sample (23.6%) married. In terms of disability 31.8%
had no ADL/IADL disability, 30.9% had only IADL disabil-
ity and 36.4% had both. A higher percentage of women
with dementia had both ADL and IADL disability com-
pared to men (44.3% vs. 22.5%). Scores on the MMSE
scores ranged from 11 to 30 (mean MMSE 21.3, SD 4.8).
Dementia severity was rated mild for 60% of the sample
and 40% had moderate dementia. A high percentage of pa-
tients (78.2%) rated their health as good or very good.
Results from mapping
We were able to map all the DEMQOL domains except for
those that are dementia symptoms (cognition and ADLs
except for enjoyment of activities). One out of seven subdo-
mains of self-esteem, nine out of eighteen of health and
well-being, three out of eight of social relationships and one
out of fifteen of daily activities (one out of four of enjoyment
of activities) were mapped onto the CC75C study.
Psychometric evaluation
Table 3 shows the psychometric properties of the HRQL
scale assessed [31]. Regarding acceptability, missing data
was below the criteria of 5% (2.73%). Shapiro-Francia,
Shapiro-Wilk and Skewness test indicated that the distri-
bution of HRQL was skewed. The HRQL questionnaire
shows acceptable internal consistency reliability (α = 0.73).
Regarding convergent validity, correlations with cognition
measured with the MMSE as a continuous variable
and disability were not significant (r = 0.059, p = 0.55
and r = -0.08, p = 0.40). HRQL was not associated with
age (r = -0.048, p = 0.62) indicating acceptable discrimin-
ant validity. Regarding known groups validity the HRQL
score showed the predicted pattern amongst a priori
known groups regarding sex and self-perceived health.
Men had higher HRQL compared to women (z = 1.958,
p = 0.05). Those who rated their health as being good
or very good had higher HRQL than those who rated
it as fair or poor (z = -2.428, p = 0.02). There were no sig-
nificant differences in HRQL score according to education
and marital status. Factor analysis did not support subscales.
Factor analysis of the instrument suggested a one-factor
model (only one factor with eigenvalues above 1 accounting
for 22% of the variance).
Distribution of HRQL by socio-demographic and func-
tional variables
Tables 4 and 5 show the distribution of HRQL in the
CC75C sample. HRQL in the presence of dementia does
not vary by age. Men have higher HRQL than women.
HRQL is higher in the 81-84 and 85-89 groups than the
90+ in men, being almost constant in women. The median
HRQL score does not vary by education or type of accom-
modation. Married people with dementia and those that
were never married have higher HRQL than their
widowed counterparts. The median score does not differ
much in women but it does in men, being higher in mar-
ried men compared to widowers and women in general.
Those with only IADL disability have better HRQL than
those with no disability and those with more severe dis-
ability (including ADLs). The HRQL of those with good
self-reported health is higher than those with fair/poor
self-reported health. HRQL does not vary with cognition.
Within those that left school before age 15, the median
score is similar in those with mild and moderate severity.
However, within those who left school at age 15 or later,
HRQL was lower in those with moderate than those with
mild dementia severity. As an additional analysis, we
calculated the association between sex and severity of
depression measured with the CAMDEX (the higher the
score the higher the severity) using the Kruskal-Wallis
equality-of-populations rank test. Men’s rank sum was
1885.5 and women’s was 4219.5 (p = 0.038).
Discussion
We have assessed the distribution of HRQL in very old
individuals with mild to moderate dementia, a section of
Table 3 Psychometric properties
Psychometric property Statistic p value
Acceptability
% missing (summary score) 2.73%
Skewness
Shapiro-Wilk <0.05
Skewness test 0.056
Shapiro-Francia <0.05
Reliability
Internal consistency (alpha) 0.73
Validity
Convergent (Spearman rho)
MMSE 0.059 0.55
Disability -0.08 0.40
Discriminant
Age -0.048 0.62
Known groups
Sex (z) 1.958 0.05
Education (z) 0.751 0.45
Marital status (χ2) 2.989 0.39
Self perceived health (z) -2.428 0.02
Factor analysis 1 factor solution 22% variance
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the population with whom it is hard to conduct this kind
of research. Marital status, sex, education and self-rated
health seem to be the most important variables related
to HRQL. Dementia severity does not seem to be associ-
ated with HRQL in dementia.
Strengths
There are a number of strengths in the approach we have
taken. Firstly, this is a population-based sample of older old
adults with dementia. The study also includes both people
with dementia living in the community and institutionalised
populations. The present study did not specifically set out
to measure dementia-specific HRQL. However, we have
been able to maximise its value by mapping most dimen-
sions of the DEMQOL onto this project and studying the
distribution of HRQL in a representative sample of the
Cambridge population over 80 years old with dementia.
One of the strengths of the DEMQOL conceptual frame-
work is that it was developed using a combination of inter-
views with people with mild to severe dementia and their
non-professional caregivers, and a review of the literature
and existing instruments. The adapted version of the
DEMQOL using the CC75C study questions has been
shown to have acceptable psychometric properties suggest-
ing that this scale fulfils standard criteria for acceptability,
good internal consistency, and validity, namely content
validity, discriminant validity and to some extent, known
group differences. These properties have been tested in a
population sample, providing therefore evidence of external
validity of this instrument. Something no other dementia-
specific measure has proved yet [18]. Another strength of
our instrument is the breadth of dimensions measured
compared to dimension-specific instruments such as the
Progressive deteriorations Scale (PDS) [33] or a number of
other dementia-specific HRQL measures [34-38].
Weaknesses
Several limitations need to be taken into account when
analysing these results. The sample used in this study
Table 4 Distribution of HRQL in total and stratified
by sex
Distribution of HRQL Women Men Total
Age Median &
interquartile
difference
Median &
interquartile
difference
Median &
interquartile
difference
81–84 14 11 12
4 4 5
85–89 14 11 11
5 6 5
90+ 11 12 11
8 5 3
Sex
Men - - 13
4
Women - - 11
6
Education
Left school <15 years old 13 11 12
4 4 5
Left school ≥15 years old 13 11 12
4 7 6
Accommodation
House/flat 13 11 12
4 5 5
Warden controlled 13 12 13
7 5 5
Residential home 12 13 13
2 6 5
Long stay hospital 3 - 3
0 - 0
Marital status
Married 14 10 13
2 5 3
Widowed 12 11 11
7 5 6
Separated/divorced - 11 11
- 0 0
Never married 13 13 13
5 1 2
Disability
No ADL or IADL 12 12 12
4 5 5
IADL only 14 11 13
4 2 5
ADL + IADL 12 11 11
2 5 5
Table 4 Distribution of HRQL in total and stratified
by sex (Continued)
MMSE
Moderate 13 12 12
5 4 5
Mild 13 11 12
4 6 5
Self-rated health
Very good/good 13 12 13
4 5 5
Fair/poor 11 8 9
8 5 4
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was derived from several phases of a longitudinal cohort
investigating HRQL in people with dementia. The use of
this data may therefore result in a number of biases in
the research, for example survival bias in which there
might have been a selection of people with factors asso-
ciated to survival or follow up such as gender, education
or setting, may lead to some unrepresentative distribu-
tions of HRQL. Cognitive bias may also be affecting the
results of this study given the lack of insight of people with
dementia [39]. However evidence suggests that people with
mild to moderate dementia are able to assess their HRQL
[22,28,40,41]. There are other limitations, principally aris-
ing from the methodology of exploring HRQL, previously
un-researched in this sample in which HRQL had not been
assessed using existing dementia-specific measures. Firstly,
since the instrument has been designed a posteriori, the
question stems, response options and time frame of the
questions were not identical to those from the DEMQOL
framework. A limitation of our instrument compared to
other instruments such as the ADRQL [13], QUALIDEM
[20] or DEMQOL proxy [22] is that HRQL in people with
severe dementia could not be analysed given the high per-
centage of missing values and the lack of proxy ratings
for HRQL items. Compared to the original DEMQOL
[22] and Bath Assessment of Subjective Quality of Life in
Dementia (BASQID) [42] our instrument did not include
items on worry/satisfaction with cognition and activities
of daily living. Regarding the psychometric properties,
some aspects such as test-retest reliability could not be
evaluated due to the study design. Causality in the associa-
tions between HRQL and covariates cannot be inferred in
this study, as it is cross-sectional. Finally, the distribution
by ethnicity, medication or relationship with the caregiver
could not be explored. These variables have been shown
to be associated in previous studies [29,43].
Summary of distribution of HRQL
Age was not associated with HRQL, a finding consistent
with previous literature [42,44-47]. Findings such as the
lower HRQL in men with dementia who are 90 years of
age and older compared to younger groups may be due
to differential mortality between gender [48]. The oldest
age group is likely to have worst health than the other two
age groups. The established relationship between married
Table 5 Distribution of HRQL stratified by cognition
Distribution of HRQL Moderate dementia Mild dementia
Age Median &
interquartile
difference
Median &
interquartile
difference
81–84 12 13
5 5
85–89 12 11
6 5
90+ 12 11
5 3
Sex
Men 13 13
5 4
Women 12 11
4 6
Education
Left school <15 years old 12 11
6 5
Left school ≥15 years old 7 13
9 6
Accommodation
House/flat 11 12
5 5
Warden controlled 13 11
2 9
Residential home 13 11
3 5
Long stay hospital 3 -
0 -
Marital status
Married 13 13
4 3
Widowed 12 11
6 6
Separated/divorced 11 -
0 -
Never married 13 13
4 3
Disability
No ADL or IADL 10 12
7 5
IADL only 13 12
4 6
ADL + IADL 12 11
6 6
Table 5 Distribution of HRQL stratified by cognition
(Continued)
Self-rated health
Very good/good 13 13
6 4
Fair/poor 10 8
6 9
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state and higher HRQL in men is found for men with de-
mentia too. This could be related to social support mecha-
nisms given one of the primary benefits of marriage for
men is social connectedness [49]. According to the sex
role hypothesis, this positive effect of marriage would not
affect women because of the ungratifying nature of house-
work (usually conducted by women) and women’s primary
responsibility for household chores [50,51]. This lack of ef-
fect of marriage in women and the high percentage of
widowed women and married men could account for the
higher HRQL of men. The finding that men have higher
HRQL than women could also indicate that women had
higher levels of, for example depression and anxiety, as oc-
curs in the general population [52,53]. In fact we have
found that in our sample, women have higher levels of de-
pression than men. This finding is consistent with what is
observed in clinical practice when offering support to rela-
tives of patients with Alzheimer’s disease, and could also
be related to the greater difficulties women face in terms
of continuing to perform the tasks associated with their
role in the family and generational context [46]. Similar
results have been reported in other populations [54-56].
HRQL did not vary by levels of cognition and its
association with disability is not clear. There is in-
creasing evidence that severity of dementia may not
be a major determinant of HRQL in dementia, indi-
cating that it is possible to have good life quality at
all levels of dementia severity [22,23,40,57]. This
finding casts doubts on the usefulness of interven-
tions only aimed at improving or maintaining cogni-
tion and function in order to improve the quality of
life of the patient with dementia. However, there is also
evidence pointing at the decreased awareness of their cog-
nitive impairments and change of behaviour by patients
with dementia [58]. This also manifests as poor awareness
of deficits in ADL. In general, awareness of deficits seems
to decrease with an increased severity of dementia [39,59].
This could account for the lack of association between se-
verity and HRQL. In fact, people with moderate dementia
severity who left school after age 14 had a very low HRQL
score compared to those with the same level of education
but higher cognition and to those who left school before
that age. This may reflect that this group are more con-
scious of their limitations in relation to more intellectual
tasks, e.g. reading for pleasure, than people with less for-
mal education, who may be less troubled by such impair-
ments. This could also be related with the cognitive
reserve hypothesis [60]. There is evidence showing that
high cognitive reserve groups have a higher cognitive de-
cline but later [61,62]. A systematic review, found cogni-
tive decline to be associated to HRQL [23]. Patients with
high reserve and moderate dementia might be more wor-
ried about the sudden decline of their functioning com-
pared to the other groups.
Finally, higher HRQL in those with good self-rated health
compared with people with lower self-rated health has also
been previously reported [47]. Whereas it is plausible that
health itself may be related to HRQL, the subjective nature
of the rating of both concepts and the inclusion of a similar
item as part of the concept of HRQL may partly explain
this association.
Future directions
Many population-based studies on dementia exist. None
of them set out to measure dementia-specific HRQL.
However, a number of these studies include variables
that could be used to map a dementia-specific HRQL
framework into the study. Doing so would be a useful
way of maximising already existing resources and allow
comparison across populations and provide valuable in-
formation for policy development.
Conclusion
To our knowledge this is the first study that has mapped
an existing conceptual framework of dementia-specific
HRQL onto an existing study that did not aim at measur-
ing it, thereby describing HRQL in an under-researched
section of the population of increasing clinical importance.
These results have practical implications for public health
policies and dementia care. They emphasise the need for
taking gender into account when assessing and imple-
menting programmes to improve HRQL. According to
the present findings, improving social support and modi-
fying sex roles that can decrease HRQL when affected by
dementia such as women’s family tasks will be key in these
programmes.
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